Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications

NCT00779116 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00779116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00779116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2005
Completion date
October 31, 2005
Enrollment
217 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergies